Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F0ZT0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $81,118
Award facts
- Contract value 100% obligated
- $81,118.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $81,118.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Zepbound 5 mg/0.5 mL pens with a completion date of January 13, 2026. Zepbound is a semaglutide-based medication used for weight management, and this delivery order represents a task order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation, and performance will be executed from the company's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems.
AmerisourceBergen's parent company, Cencora, Inc., holds a $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical through December 2031, which serves as the comprehensive vehicle supporting this and similar pharmaceutical delivery orders. This prime contract enables the supply of a broad range of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities to support military treatment facilities and other federal medical institutions globally. The delivery order structure and firm fixed-price arrangement allow DLA to efficiently procure specific medications such as Zepbound as needed for military personnel and beneficiaries, demonstrating the company's established capability to fulfill critical pharmaceutical supply requirements through open competition.
Quick answers
Who was awarded contract SPE2DR26F0ZT0?
SPE2DR26F0ZT0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F0ZT0 worth?
The government has obligated $81,118 on SPE2DR26F0ZT0.
Is contract SPE2DR26F0ZT0 an order under another contract?
Yes. SPE2DR26F0ZT0 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F0ZT0 competed?
The extent of competition for SPE2DR26F0ZT0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award